S.Res. 529 was co-sponsored by Sens. Daniel Akaka (D-Hawaii), Ben CardinBen CardinSenate GOP ties Iran sanctions fight to defense bill Lawmakers push to elevate Cyber Command in Senate defense bill Baltimore police officer cleared in Freddie Gray case MORE (D-Md.), Saxby ChamblissSaxby ChamblissWyden hammers CIA chief over Senate spying Cruz is a liability Inside Paul Ryan’s brain trust MORE (R-Ga.), Daniel Inouye (D-Hawaii) and Ron WydenRon WydenPuerto Rico debt relief faces serious challenges in Senate Senate panel delays email privacy vote amid concerns Overnight Finance: Puerto Rico bill clears panel | IRS chief vows to finish term | Bill would require nominees to release tax returns MORE (D-Ore.).
Other sponsors of the measure — which passed by unanimous consent — are also prostate cancer survivors.
“I understand firsthand the importance of prevention, testing and early detection,” said Chambliss, who successfully battled prostate cancer. “While prostate cancer affects all men, the National Institutes of Health has found that it disproportionately affects minorities, and African Americans in particular.”
The National Institutes of Health (NIH) has found that although the prostate cancer death rate has declined for both white men and African American men in recent years, the disparity in deaths from this disease persists. The organization is sponsoring research to determine what factors could be contributing to the higher incidence and death rates among African American men.
Cardin’s office said the research shows that even after accounting for those who lack health insurance, minority racial and ethnic groups face inequities in access and treatment and preventative care. Cardin wrote provisions in the Affordable Care Act that elevated the new Institute of Minority Health and Health Disparities at NIH, to help eliminate those health disparities.
“Preventive healthcare saves lives, and it is particularly effective in reducing mortality for prostate cancer,” Cardin said.